Definitive Contract 12639521C0052
Award Date
7/19/21
Potential Completion Date
7/18/26
Potential Value
$232K
Funding Federal Agency
Veterinary Services
Contracting Federal Agency
Marketing and Regulatory Programs Business Services
Awardee
Roche Diagnostics Corporation
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Ames, IA 50010, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $787,038.78 firm fixed-price delivery order contract awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and medical products. The contract, which has no set-aside designation, provides for the delivery of Roche's medical diagnostic technologies, including laboratory equipment, testing systems, reagents, and clinical testing services, to support...
This federal contract award, valued at $206,474.84, was made by the Department of Veterans Affairs (VA) Veterans Health Administration to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the delivery of molecular testing supplies and is not subject to a set-aside designation. Roche Diagnostics has a history of providing critical care analyzers, reagents, test...
This is a delivery order contract awarded by the Defense Health Agency (DHA), a defense agency, to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and associated products and services. The $341,575.26 firm-fixed-price contract provides reagents under the Critical Analyzers, Laboratory GSA Schedule contract (FSS-66-III). The contract has an ultimate completion date of March 31, 2025. Roche Diagnostics has a history of providing medical equipment,...
This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The $112,018.90 firm-fixed-price delivery order was placed against Roche's existing General Services Administration (GSA) Schedule contract for Critical Analyzers and Laboratory Equipment (FSS-66-III). This order provides the VA with clinical chemistry...
The Department of Veterans Affairs Veterans Health Administration has awarded a $23,741.00 Firm Fixed Price Delivery Order contract to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory equipment. This contract is for the provision of coagulation testing supplies to support VA healthcare facilities. The contract has no set-aside designation and a completion date of January 31, 2024. Roche Diagnostics holds several Indefinite...
This is a definitive contract awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 22 to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The $124,341.72 firm fixed-price contract is for laboratory maintenance services and does not have a set-aside designation. Roche Diagnostics has multiple significant Indefinite Delivery Vehicles and Blanket Purchase Agreements with federal...
This is a Firm Fixed Price delivery order awarded by the Veterans Integrated Service Network 6 (VISN 6) of the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The $4,166.40 contract is for an annual service agreement with a completion date of December 31, 2024. Roche Diagnostics is not a set-aside awardee for this contract. The contract is part of Roche's existing...
This is a $311,081.10 firm-fixed-price purchase order contract awarded by the Veterans Integrated Service Network 9 of the U.S. Department of Veterans Affairs to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostic products and laboratory instruments. The contract is for the provision of an ANALYZER and has an ultimate completion date of April 19, 2027. The award is not associated with a set-aside program. Roche Diagnostics holds multiple Indefinite...
This firm fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $116,048.25 contract provides Roche Diagnostics' reagents for the VA's Veterans Health Administration facilities. Roche Diagnostics has a history of providing critical care medical equipment, reagents, and testing services to federal...
This is a federal contract award from the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $44,566.24, is for the provision of ROCHE HE600 and BENCHMARK reagents. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is July 29, 2026. The contract is not...